Phase II Study of a Temozolomide-Based Chemo-radiotherapy Regimen for High Risk Low-Grade Gliomas: Long-term Results of Radiation Therapy Oncology Group (RTOG) 0424
To report the long-term outcomes of the YYY1 study of a high-risk low-grade gliomas (LGG) population treated with concurrent and adjuvant temozolomide (TMZ) and radiotherapy (RT).
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Barbara J. Fisher, Stephanie L. Pugh, David R. Macdonald, Arnab Chakravatri, Glenn J. Lesser, Sherry Fox, C. Leland Rogers, Maria Werner-Wasik, Thomas Doyle, Jean-Paul Bahary, John B. Fiveash, Joseph A. Bovi, Steven P. Howard, Hsiang-Hsuan Michael Yu, Dav Source Type: research
More News: Biology | Brain Tumor | Cancer & Oncology | Glioma | Physics | Radiation Therapy | Radiology | Study | Temodar